AnalystsMadison El-SaadiMadison El-Saadi's Stock Forecasts
AnalystsMadison El-Saadi
Analyst Ranking
Top 28%
#1488 out of 5327 analysts
Average Return
+17.72%
Win Rate
59%10 out of 17
Risk vs Reward
Poor
Good
Madison El-Saadi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +198.62% | $10.18 | $30.40 | 2025-06-26 - 2026-06-25 | Strong Buy |
Axsome Therapeutics IncAXSM | +86.93% | $118.57 | $221.64 | 2025-10-01 - 2026-07-20 | Strong Buy |
Eton Pharmaceuticals IncETON | +84.01% | $22.32 | $41.07 | 2026-03-20 - 2026-07-20 | Strong Buy |
Eton Pharmaceuticals IncETON | +59.85% | $18.93 | $30.26 | 2025-05-16 - 2026-05-15 | Strong Buy |
Eton Pharmaceuticals IncETON | +27.82% | $14.88 | $19.02 | 2025-03-19 - 2026-03-18 | Strong Buy |
Madison El-Saadi Analyst Color
Get additional color on Madison El-Saadi's coverage of popular stocks
Madison El-Saadi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Spruce Biosciences IncSPRB | 1 | Strong Buy | $160.00 | +259.55% | Initiates Coverage On | 9 days ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $17.00 | +45.67% | Initiates Coverage On | 3 months ago |
Eton Pharmaceuticals IncETON | 4 | Strong Buy | $31.00 | -24.52% | Maintains | 4 months ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $63.00 | +223.08% | Maintains | 4 months ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Strong Buy | $101.00 | +40.96% | Maintains | 6 months ago |
Vanda Pharmaceuticals IncVNDA | 2 | Strong Buy | $14.00 | +163.16% | Maintains | 7 months ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $37.00 | +545.72% | Maintains | 7 months ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $179.00 | -19.24% | Initiates Coverage On | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.